... regimen in accordance to priorphase I experience [1,26]. Viability of BEXIDEM was rou-tinely assessed and no breech of protocol was noted in processing, handling or administering the product rulingout ... BEXIDEM was reflected in increased urinary interleukin-8 (IL-8), granulocyte-mac-rophage colony-stimulating factor (GM CSF), IL-18,elastase and neopterin indicating neutrophil and mac-rophages ... were in risk groupA, 11 were in group B, and 4 were in group C. In the BCGgroup, 6 of these patients were in risk group A, 3 were in group B, and 1 was in group C. Progression to muscleinvasive...